✦ LIBER ✦

Phase II trial of intravenous 6-thioguanine for unresectable or metastatic non-small cell bronchogenic carcinoma

✍ Scribed by Frank V. Fossella; Rodger J. Winn; Paul Y. Holoye; Martin N. Raber; Larry Holden; Robert Belt; Heather Allen; Becky Hallinan; Karen Harper

Publisher: Springer US
Year: 1991
Tongue: English
Weight: 132 KB
Volume: 9
Category: Article
ISSN: 0167-6997
DOI: 10.1007/bf00183586

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of trimetrexate for unres

Phase II trial of trimetrexate for unresectable or metastatic non-small cell bronchogenic carcinoma

✍ Frank V. Fossella; Rodger J. Winn; Paul Y. Holoye; Becky Hallinan; Martin N. Rab 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 368 KB

Phase II trial of 4′ deoxydoxorubicin (D

Phase II trial of 4′ deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma

✍ Christopher Rose; Thomas E. Lad; Lary J. Kilton; Joel Schor; Steven T. Rosen; Ar 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 162 KB

A phase II trial of 4' Deoxydoxorubicin (DXDX) was conducted in unresectable previously untreated non-small cell lung cancer patients. DXDX was administered every 3 weeks by short intravenous infusion at a starting dose of 30 mg/m2, with dose escalation to 40 mg/m2 toxicity permitting. Four response

Phase II trial of caracemide (NSC 253272

Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma

✍ Thomas Lad; Joel Schor; Michael Mullane; Rosemary Carroll; David Chernicoff; Ric 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 126 KB

A phase II trial of ilmofosine in non-sm

A phase II trial of ilmofosine in non-small cell bronchogenic carcinoma

✍ Paul V. Woolley; Carolyn J. Schultz; Gladys I. Rodriguez; Richard A. Gams; Kenne 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 300 KB

Phase II trial of 5 day continuous intra

Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck

✍ Flavio Kruter; Mario Eisenberger; Victoria Sinibaldi; Christine Engstrom; Maria 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 221 KB

Phase II trial of 6-thioguanine administ

Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer

✍ Stephen K. Williamson; John Crowley; Robert B. Livingston; Geoffrey Weiss 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 201 KB